U.S. Biotech Stock News

Why EQT stock is in focus right now A powerful cold front across the US has pushed natural gas prices sharply higher, and EQT (EQT), the country’s largest gas producer, has moved with the commodity as traders reassess supply and demand. This weather driven price action, combined with expectations for supply deficits in key regions, has turned attention back to how EQT’s size, hedging program and balance sheet plans might shape the stock’s risk and reward profile. See our latest analysis for...

Apollo Global Management (NYSE:APO) is leading a $3.5b capital solution for Valor Compute Infrastructure to support a $5.4b acquisition and lease tied to xAI focused AI data center assets. The firm also completed about €900m in secured financing for a large European logistics and industrial real estate portfolio. These moves expand Apollo’s exposure to AI focused digital infrastructure and European logistics real assets. Shares of Apollo Global Management trade at $134.54, with the stock...

The Walt Disney Company recently appointed longtime media analyst Benjamin Swinburne as Executive Vice President of Investor Relations and Corporate Strategy, giving him responsibility for investor communications, long-term strategic planning, and market analysis across its entertainment ecosystem. This hire brings a veteran Wall Street analyst with deep sector expertise inside Disney just as investors scrutinize its transition toward streaming, digital experiences, and an upcoming CEO...

XPeng (NYSE:XPEV) is launching its XPENG P7+ sedan across 36 countries at the same time, expanding its presence in global electric vehicle markets. The model is being shown at the Brussels Motor Show, a major European auto event that attracts international industry attention. The company is also working on AI, in-house chip development, humanoid robots, and flying vehicles as part of its next generation mobility plans. For anyone tracking NYSE:XPEV, this move places the company within the...

SL Green Realty (SLG) just posted fourth quarter funds from operations and revenue that topped Wall Street expectations, alongside strong Manhattan leasing metrics and updates on its multibillion dollar refinancing and asset sale programs. See our latest analysis for SL Green Realty. Despite the quarterly beat, SL Green Realty's share price has been under pressure, with a 30 day share price return showing a 4.64% decline and a 1 year total shareholder return showing a 30.44% decline, pointing...

Peoples Financial Services (PFIS) has wrapped up FY 2025 with fourth quarter revenue of US$45.8 million and EPS of US$1.20, alongside trailing twelve month revenue of US$187.6 million and EPS of US$5.92, capped by a trailing net profit margin of 31.6% versus 7.4% a year earlier. Over the past few quarters, revenue has moved from US$40.8 million in Q4 2024 to US$48.7 million in Q2 2025 before landing at US$45.8 million in Q4 2025. Quarterly EPS shifted from US$0.61 in Q4 2024 to US$1.70 in Q2...

Why Aurora Innovation’s McLeod integration matters now Aurora Innovation (AUR) recently completed early integration of its Aurora Driver into McLeod Software’s Transportation Management System. This is a commercial step that lets freight customers manage autonomous truck capacity inside existing logistics workflows. See our latest analysis for Aurora Innovation. The McLeod integration and upcoming Q4 2025 results have arrived during a choppy period for Aurora’s stock, with a 1 month share...

In late January 2026, Oracle announced its Life Sciences AI Data Platform and secured new wins with IHG Hotels & Resorts, Alrajhi Medicine, and Voisin Consulting Life Sciences, while deepening its role as cloud and data-security provider to TikTok U.S. amid an ongoing AI data-center buildout. These moves highlight how Oracle is trying to turn very large AI-related capital commitments and extensive OpenAI exposure into cloud, healthcare, life sciences, and hospitality revenue streams, even as...

In late January 2026, The Goldman Sachs Group, Inc. reported strong fourth-quarter results, raised its quarterly dividend by nearly 13% to US$4.50 per share, and highlighted expectations for increased investment banking activity. At the same time, Goldman Sachs deepened its relationship with Qatar Investment Authority through a preliminary agreement targeting up to US$25.00 billion in investments into Goldman-managed vehicles and co-investments, underscoring expanding opportunities across...

Wondering whether UiPath shares offer value at today's price, or if the market is pricing in too much hope already? This article walks through what the numbers are actually saying about the stock. UiPath's recent share price has moved to US$12.59, with returns of 14.9% decline over 7 days, 20.7% decline over 30 days, 20.7% decline year to date, 11.5% decline over 1 year and 25.5% decline over 3 years. Recent coverage has focused on UiPath as an AI and automation player in a competitive...

Biogen's litifilimab (BIIB059) has received FDA Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus. The designation is based on Phase 2 trial results that suggest litifilimab may address an unmet medical need in CLE. This status may allow for expedited development and review of the therapy by the FDA. For investors watching NasdaqGS:BIIB, the new designation comes with the stock trading at $179.89 and a 25.0% return over the past year, while longer term...

If you are wondering whether Elevance Health's current share price offers good value or not, it helps to look past the headlines and focus on what the numbers are saying. The stock last closed at US$345.74, with returns of a 6.8% decline over 7 days, a 2.4% decline over 30 days, a 2.4% decline year to date, and a 10.9% decline over 1 year, while the 5 year return sits at 27.2%. Recent news around Elevance Health has centered on broader healthcare policy discussions and insurer sentiment,...

Pfizer agreed to acquire Metsera for $10 billion, aiming to expand into obesity and weight loss drugs. The company is reshaping its R&D focus toward metabolic disease, oncology and immunology. Pfizer signed a licensing deal with Novavax for Matrix M adjuvant technology to support vaccine development. Pfizer (NYSE:PFE), trading around $26.44, is trying to reposition itself after a difficult multi year share price period, with a reported 28.1% decline over 3 years and 2.8% decline over 5...

If you are wondering whether Planet Fitness shares offer good value at current levels, this article walks through what the numbers actually say about the stock. The share price closed at US$91.04, with returns of a 3.6% decline over the last 7 days, 17.0% decline over 30 days, 17.0% decline year to date, 15.8% decline over 1 year, 11.1% gain over 3 years and 17.0% gain over 5 years, which gives a mixed picture for anyone thinking about long term performance. Recent news flow around Planet...

Mondelez International (MDLZ) has put leadership in sharper focus, asking long-time Chief Financial Officer Luca Zaramella to also serve as Chief Operating Officer, centralizing financial and commercial decision making under one experienced executive. See our latest analysis for Mondelez International. The leadership reshuffle comes as the share price trades at US$58.47, with a 1 month share price return of 8.98% and a 1 year total shareholder return of 4.01%, while the 3 year total...

On January 29, 2026, Keysight Technologies and Point2 Technology announced a collaboration to validate Point2’s e-Tube interconnects aimed at easing AI and machine learning data center bottlenecks using Keysight’s high-speed digital test platforms. The partnership highlights how test and measurement expertise can become a critical enabler for hyperscalers seeking lower-power, longer-reach alternatives to traditional copper and optics in xPU clusters. With this AI-focused collaboration in...

Why Perella Weinberg Partners (PWP) is on investors’ radar Perella Weinberg Partners (PWP) has drawn attention after a month return of about 27% and a past 3 months gain of roughly 21%, prompting investors to reassess its advisory driven business and recent financial metrics. See our latest analysis for Perella Weinberg Partners. The recent 30 day share price return of 27.1% and 90 day gain of 20.6% at a latest share price of $22.31 suggest building momentum. This comes alongside a mixed...

If you are wondering whether Viper Energy at around US$42.34 still offers value, you are not alone, especially with energy stocks often moving in sharp cycles. Over the last week the share price return was 6.8%, with a 9.2% return over the past month, although the return over the last year was a 4.3% decline. Recent news flow around Viper Energy has focused on its role as a mineral and royalty interest owner in the Permian Basin and how its asset base ties into broader US oil and gas...

Investors in Meta Platforms, Inc. ( NASDAQ:META ) had a good week, as its shares rose 8.8% to close at US$717 following...

Solos Technology has filed a patent infringement lawsuit against Meta Platforms (NasdaqGS:META) over smart glasses technology. The complaint targets Meta's Ray-Ban smart glasses and claims infringement of multiple Solos patents tied to audio, sensing, and real-time user interaction. Solos is seeking significant damages and an injunction that could affect Meta's wearables business and broader platform plans. The lawsuit also cites alleged internal awareness at Meta of Solos' patents before...

As you might know, Axos Financial, Inc. ( NYSE:AX ) just kicked off its latest quarterly results with some very strong...

Bankwell Financial Group, Inc. ( NASDAQ:BWFG ) last week reported its latest annual results, which makes it a good time...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Citizens...

Sound Financial Bancorp, Inc.'s ( NASDAQ:SFBC ) dividend will be increasing from last year's payment of the same period...